NCT06192940 Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement
| NCT ID | NCT06192940 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Sud Francilien |
| Condition | Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-03-28 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2024-03-28 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?
Eligibility Criteria
Inclusion Criteria: * Older than 18 years patient with type 1 or 2 diabetes * Treated with multiple insulin injections * Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before * Dependent on a health professional for treatment management. * Subject informed of the study and not objecting to data collection. Exclusion Criteria: \- Patient refusing study.
Contact & Investigator
Marie BOULY, APN
PRINCIPAL INVESTIGATOR
Centre Hospitalier Sud Francilien
Frequently Asked Questions
Who can join the NCT06192940 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06192940 currently recruiting?
Yes, NCT06192940 is actively recruiting participants. Contact the research team at marie.bouly@chsf.fr for enrollment information.
Where is the NCT06192940 trial being conducted?
This trial is being conducted at Corbeil-Essonnes, France.
Who is sponsoring the NCT06192940 clinical trial?
NCT06192940 is sponsored by Centre Hospitalier Sud Francilien. The principal investigator is Marie BOULY, APN at Centre Hospitalier Sud Francilien. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.